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a  b  s  t  r  a  c  t
Fucogalactans  from  edible  Agaricus  bisporus  (RFP-Ab)  and  wild  Lactarius  rufus  (RFP-Lr)  mushrooms  were
obtained  on  aqueous  extraction  followed  by  puriﬁcation.  RFP-Ab  had  Mw 43.8  × 104 g mol−1 and  RFP-
Lr  Mw 1.4  ×  104 g  mol−1. RFP-Lr  had  a (1 →  6)-linked  -d-Galp  main-chain  partially  substituted  at  O-2
by  nonreducing  end-units  of  -l-Fucp  (29%).  While  RFP-Ab  had  a  similar  main  chain,  it was  partially
substituted  at  O-2  by  nonreducing  end-units  of  -l-Fucp  (2.8%)  and  -d-Galp  (14.5%),  and  partially  methy-eywords:
dible mushrooms
garicus bisporus
actarius rufus
ucogalactans
lated  at  HO-3.  Both  RFP-Lr  and  RFP-Ab  were  tested  in mice  against  polymicrobial  sepsis.  Lethality  rate,
myeloperoxidase  (MPO)  activity  and  cytokine  levels  were  determined.  It was  observed  a reduction  in
late mortality  rate  by  62.5%  and  50%,  respectively,  prevention  of  neutrophil  accumulation  in  ileum  and
decreasing  in TNF- and  IL-1  serum  levels.
© 2011 Elsevier Ltd. Open access under the Elsevier OA license.
epsis
. Introduction
Mushrooms have been used as therapeutic agents and valuable
ood sources for centuries in Asia, especially because of their chem-
cal composition and nutritional values. They have high protein
nd ﬁber contents with small amounts of fat (Lakhanpal & Rana,
005; Manzi, Aguzzi, & Pizzoferrato, 2001), and can be considered
s functional foods, which can provide health beneﬁts beyond the
raditional nutrients they contain.
The practice of using hot-water extracts and decocts of mush-
ooms in oriental medicine, particularly in China, is the basis of
odern studies on the medicinal properties. Approximately 300
pecies are known to have medicinal or nutraceutical properties
nd another 1800 have been identiﬁed, which have prospective
edicinal properties (Lakhanpal & Rana, 2005).
From these, a great variety of active molecules, featur-
ng immunomodulatory and antitumoral properties, reduction
f blood pressure, among others (Wasser, 2002; Zhang, Cui,
heung, & Wang, 2007), have been identiﬁed in many mush-
ooms species. Among these, polysaccharides isolated from fruiting
odies, mycelia, and culture media (Zhang et al., 2007) deserve
ttention.
∗ Corresponding author. Tel.: +55 41 3361 1655; fax: +55 41 3266 2042.
E-mail address: iacomini@ufpr.br (M.  Iacomini).
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oi:10.1016/j.carbpol.2011.09.071
Open access under the Elsevier OA license.Several polysaccharides have been isolated from basid-
iomycetes, such as linear or branched glucans and heterogalactans,
which can contain O-methyl groups or a variety of side chains
(Wasser, 2002; Zhang et al., 2007). Most heterogalactans have a
main chain composed of (1 → 6)-linked -d-Galp units with mainly
fucose or mannose as substituents (Carbonero, Gracher, Komura,
et al., 2008; Carbonero, Gracher, Rosa, et al., 2008; Rosado et al.,
2003; Smiderle et al., 2008; Wasser, 2002; Zhang et al., 2007),
although there are few studies relating their detailed structure and
biological activity.
Many of these polysaccharides have been evaluated as bio-
logical response modiﬁers, especially for their antitumor activity
(Moradali, Mostafavi, Ghods, & Hedjaroude, 2007; Wasser & Weis,
1999; Zhang et al., 2007). Some reports have shown that extracts
from mushrooms can have other effects, such as anti-inﬂammatory
and antinociceptive activity (Komura et al., 2010; Smiderle
et al., 2008). However, it is not possible to attribute a relation
between structure and activity, because most of the investigations
were carried out using crude polysaccharide extracts (Lindequist,
Niedermeyer, & Julich, 2005; Poucheret, Fons, & Rapior, 2006).
Recent studies concerned anti-inﬂammatory and antinociceptive
effects of fucogalactans, fucomannogalactans, and mannogalactans
isolated from Agaricus brasiliensis and Agaricus bisporus var. hort-
ensis (Komura et al., 2010), Lentinus edodes (Carbonero, Gracher,
Komura, et al., 2008), and Pleurotus pulmonarius (Smiderle et al.,
2008), respectively.
However, there are very few reports dealing with the ability of
mushroom polysaccharides in reducing mortality caused by sepsis
A.C. Ruthes et al. / Carbohydrate Pol
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tig. 1. Scheme of extraction and puriﬁcation of fucogalactans from A. bisporus (Ab)
nd  L. rufus (Lr).
n mice. Sepsis is a considerable health problem and a leading cause
f morbidity and mortality in many intensive care units. It rep-
esents a state of overproduction of pro-inﬂammatory mediators
hich frequently occurs after various noxious injuries, especially
acterial infection, as a consequence of abdominal surgery, appen-
icitis, perforated ulcers, or an ischemic bowel (Angus et al., 2001).
Thus, in order to compare chemical structure with biological
roperties of mushroom polysaccharides, structures of fucogalac-
ans isolated from the worldwide consumed mushroom A. bisporus
champignon de Paris; RFP-Ab), and from Lactarius rufus (RFP-Lr),
hich is used as condiment (Phillips, 2006), were now character-
zed. Their activities against murine sepsis, namely their effects
n lethality, neutrophil migration and cytokine levels were also
nvestigated.
. Materials and methods
.1. Biological materials
Dried fruiting bodies of A. bisporus (champignon de Paris)
ere provided by Makoto Yamashita Company (Miriam Harumi
amashita), Sao José dos Pinhais, State of Paraná, Brazil. L. rufus
ruit bodies were collected in middle of May, 2005 from soil of a
inus sp. reforestation project located in Mafra, State of Santa Cata-
ina, Brazil at latitude: 26◦13′S; longitude: 49◦50′W and altitude
f 826 m above sea level. This mushroom sample was taken to the
aboratory within 12 h of collection, cleaned up from forest debris
without washing) with a plastic knife, and dried in a freeze-dryer.
ried samples were then ground.
.2. Extraction and puriﬁcation of fucogalactans
Extraction of crude polysaccharides and their puriﬁcation was
arried out as in Fig. 1. Wiley-milled powder fruiting bodies from
. bisporus (100 g) and L. rufus (42 g) were extracted with H2O at
◦C for 6 h (6×;  2000 ml). The combined aq. extracts were added
o excess ethanol (EtOH, 3:1; v/v) to precipitate polysaccharide,ymers 87 (2012) 1620– 1627 1621
which was collected by centrifugation (8000 rpm at 5 ◦C for 20 min).
Each sediment was  then dissolved in H2O, dialyzed against tap
water for 20 h to remove low-molecular-weight carbohydrates,
giving rise to solutions containing fractions CW-Ab and CW-Lr,
respectively. These were frozen and then allowed to thaw slowly
(Gorin & Iacomini, 1984), resulting in insoluble fractions ICW-Ab
and ICW-Lr, which were separated by centrifugation as described
above. The supernatant fractions SCW-Ab and SCW-Lr, were treated
with Fehling solution (Jones & Stoodley, 1965), giving precipitated
Cu2+ complexes (FP-Ab and FP-Lr, respectively), which were sep-
arated by centrifugation. The precipitates were neutralized with
acetic acid (HOAc), dialyzed against tap water (48 h), deionized with
mixed ion exchange resins, and then freeze-dried.
Each fraction was further puriﬁed by closed dialysis through a
membrane with a 100 kDa Mr cut-off (Spectra/Por® Cellulose Ester),
giving rise to an eluted (EFP) and a retained (RFP) material (Fig. 1).
2.3. Monosaccharide composition of polysaccharides
Each polysaccharide fraction (1 mg)  was  hydrolyzed with 2 M
TFA at 100 ◦C for 8 h, followed by evaporation to dryness. The
residues were successively reduced with NaBH4 (1 mg)  and acety-
lated with Ac2O-pyridine (1:1, v/v; 200 l) at 100 ◦C for 30 min
following the method of Sassaki et al. (2008).  The resulting alditol
acetates were analyzed by gas chromatography–mass spectrom-
etry (GC–MS), using a Varian model 3300 gas chromatograph
linked to a Finnigan Ion-Trap, Model 810-R12 mass spectrome-
ter. Incorporated was  a DB-225 capillary column (30 m × 0.25 mm
i.d.) programmed from 50 to 220 ◦C at 40 ◦C min−1, then hold, and
the alditol acetates identiﬁed by their typical retention times and
electron impact proﬁles.
2.4. Determination of homogeneity of polysaccharides and their
molecular weight (Mw)
The homogeneity and molecular mass (Mw) of the puriﬁed
fucogalactans RFP-Ab and RFP-Lr were determined by high perfor-
mance steric exclusion chromatography (HPSEC), using a refractive
index (RI) detector. The eluent was 0.1 M NaNO3, containing
0.5 g l−1 NaN3. The polysaccharide solutions were ﬁltered through
a membrane with 0.22 m diameter pores (Millipore). The spe-
ciﬁc refractive index increment (dn/dc) was  determined using a
Waters 2410 detector, the samples being dissolved in the elu-
ent, ﬁve increasing concentrations, ranging from 0.2 to 1.0 mg ml−1
being used to determine the slope of the increment.
2.5. Methylation analysis of fucogalactans
Per-O-methylation of each isolated polysaccharides (RFP-Lr and
RFP-Ab; 10 mg)  was carried out using NaOH–Me2SO–MeI (Ciucanu
& Kerek, 1984). The process, after isolation of the products by
neutralization (HOAc), dialysis, and evaporation was  repeated,
and the methylation was found to be complete. The per-O-
methylated derivatives were hydrolyzed with 45% aqueous formic
acid (HCO2H, 1 ml)  for 6 h at 100 ◦C, followed by NaB2H4 reduction
and acetylation as above (Section 2.3), to give a mixture of partially
O-methylated alditol acetates, which was  analyzed by GC–MS using
a Varian model 4000 gas chromatograph, equipped with fused sil-
ica capillary columns of CP-Sil-43CB. The injector temperature was
maintained at 220 ◦C, with the oven starting at 50 ◦C (hold 2 min)
to 90 ◦C (20 ◦C min−1, then held for 1 min), 180 ◦C (5 ◦C min−1, then
held for 2 min) and to 220 ◦C (3 ◦C min−1, then held for 5 min).
Helium was used as carrier gas at a ﬂow rate of 1.0 ml  min−1. Par-
tially O-methylated alditol acetates were identiﬁed from m/z  of
their positive ions, by comparison with standards, the results being
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xpressed as a relative percentage of each component (Sassaki,
orin, Souza, Czelusniak, & Iacomini, 2005).
.6. Nuclear magnetic resonance (NMR) spectroscopy
Mono- (13C, 1H and DEPT) and bidimensional NMR  spectra
HMQC, COSY, and coupled HMQC) were prepared using a 400 MHz
ruker model DRX Avance spectrometer incorporating Fourier
ransform. Analyses were carried out at 70 ◦C on samples dis-
olved in D2O. Chemical shifts are expressed in ı relative to acetone
t ı 32.77 (13C) and 2.21 (1H), based on DSS (2,2-dimethyl-2-
ilapentane-5-sulfonate-d6 sodium salt; ı = 0.0 for 13C and 1H).
.7. Experimental animals
Male albino Swiss mice (3 months old, weighing 25–30 g), from
he Universidade Federal do Paraná colony were used for biological
ests. They were maintained under standard laboratory conditions,
ith a constant 12 h light/dark cycle and controlled temperature
22 ± 2 ◦C), Standard pellet food (Nuvital®, Curitiba/PR, Brazil) and
ater were available ad libitum.  All experimental procedures were
reviously approved by the Institutional Ethics Committee of the
niversity (authorization number 529).
.8. Procedure to induce sepsis by cecal ligation and puncture
CLP)
Mice were randomly divided into ﬁve groups with 10
ice/group: sham-operation, CLP plus saline (10 ml kg−1 s.c.), CLP
lus RFP-Lr (30 mg  kg−1 s.c.), CLP plus RFP-Ab (30 mg  kg−1 s.c.)
nd CLP plus dexamethasone (0.5 mg  kg−1 s.c.). Saline was used
s vehicle for dissolving both polysaccharides; and dexametha-
one was commercially purchased. It was administered 60 l of
ach treatment solution, regarding the corporeal weigh of the ani-
als (∼30 g). Ketamine (80 mg  kg−1) and xylazine (20 mg  kg−1)
ere injected intraperitoneally to anesthetize the mice before the
urgical procedures. Polymicrobial sepsis was induced by CLP as
reviously described (Rittirsch, Huber-Lang, Flierl, & Ward, 2009).
 midline incision about ∼1.5 cm was performed on the abdomen.
he cecum was carefully isolated and the distal 50% was ligated. The
ecum was then punctured twice with a sterile 20-gauge needle and
queezed to extrude the fecal material from the wounds. The cecum
as replaced and the abdomen was closed in two layers. Sham-
ontrol animals were treated identically, but no cecal ligation or
uncture was carried out. Each mouse received subcutaneous ster-
le saline injection (1 ml)  for ﬂuid resuscitation after surgery. The
ice were then placed on a heating pad until they recovered from
he anesthesia. Food and water ad libitum were provided through-
ut the experiment. Survival was monitored for 7 days, each 12 h.
uring this period, saline and drugs were subcutaneously admin-
stered daily.
In other experiments, during the surgery, mice were treated sub-
utaneously with saline, RFP-Lr, RFP-Ab or dexamethasone. After
8 h post-operation, mice were sacriﬁced. Their tissues from small
ntestines (ileum) and blood were collected and frozen for later use
o determine the myeloperoxidase (MPO) activity and investigate
ytokine production in serum.
.9. Ileum MPO  activity
MPO  activity, assessment measure of neutrophil inﬂux, was
etermined according to established protocols (Bradley, Priebat,
hristensen, & Rothstein, 1982). Brieﬂy, ileum tissue was  homog-
nized in 0.5 ml  of 50 mM  potassium buffer pH 6.0 with 0.5%
exadecyltrimethylammonium bromide, sonicated on ice, and
hen centrifuged at 14,000 rpm at 4 ◦C for 15 min. Supernatantslymers 87 (2012) 1620– 1627
were then assayed at a 1:20 dilution in reaction buffer (9.6 mM
3,3,5,5-tetramethylbenzine, 150 nmol l−1 H2O2 in 50 mM potas-
sium phosphate buffer), and read at 620 nm.  Results are expressed
as change in optical density per milligram of protein (measured by
Bradford assay).
2.10. Determination of cytokines levels
Tumor necrosis factor alpha (TNF-) and interleukin (IL)-1
concentrations were determined in mice serum using enzyme
linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapo-
lis, MN)  according to the manufacturer’s instructions.
2.11. Statistical analysis
Data were expressed as means ± SE of ﬁve or ten mice exam-
ined in each group. Statistical error was determined by one-way
ANOVA; the post hoc test was Bonferroni’s. Calculations were per-
formed with Graphpad Prism 5.0. p values < 0.05 were considered
signiﬁcant.
3. Results and discussion
3.1. Fucogalactans structural characterization
Agaricus is an important fungal genus, considering that some of
its species contain polysaccharides that have been presenting sev-
eral biological activities, especially antitumor. The specie A. bisporus
is one of the most extensively cultivated and consumed mushrooms
in the world. In the other hand, Lactarius spp., such as L. rufus,
which consumption is limited to its use as a condiment in a few
countries, have not been studied in this context. In order to obtain
pure heteropolysaccharides from the fruiting bodies of A. bisporus
and L. rufus, each was  submitted to aqueous extraction at 4 ◦C. The
extracted polysaccharides were precipitated with excess ethanol,
obtained as sediments on ultracentrifugation, dialyzed against tap
water 4, and the solution freeze-dried to give CW-Ab and CW-Lr,
respectively (Fig. 1).
Fractionation and puriﬁcation of CW-Ab and CW-Lr was carried
out by a freeze–thawing procedure (Gorin & Iacomini, 1984), result-
ing in a respective cold water-soluble SCW-Ab (4.2 g) and SCW-Lr
(2.4 g) and discarded insoluble fractions.
Fraction SCW-Lr contained fucose, xylose, galactose and glucose,
while SCW-Ab had in addition, 3-O-methyl-galactose (conﬁrmed
by the presence of the fragments with m/z 130 and 190 from derived
mono-deuterated alditol acetates).
Fractions SCW-Ab and SCW-Lr gave heterogeneous HPSEC elu-
tion proﬁles, so they were then treated with Fehling solution.
Their respective insoluble Cu2+ complexes FP-Ab (2.1 g) and FP-Lr
(1.9 g) were further puriﬁed by closed dialysis through a 100 kDa
Mr cut-off membrane. This procedure gave rise to eluted EFP-Ab
and EFP-Lr and retained RFP-Ab and RFP-Lr fractions, respectively
(Fig. 1). The RFP fractions (RPF-Ab: 205 mg  and RPF-Lr: 301 mg)
were homogeneous on HPSEC, and had Mw 43.8 × 104 g mol−1
(dn/dc 0.145 ml  g−1) for A. bisporus and Mw 1.4 × 104 g mol−1 (dn/dc
0.151 ml  g−1) for L. rufus (Fig. 2A and B, respectively).
Fraction RFP-Ab contained fucose (6%), galactose (84%) and 3-
O-methyl-galactose (10%), whereas RFP-Lr, only contained fucose
(29%) and galactose (71%).
Both fractions, RFP-Ab and RFP-Lr were submitted to methy-
lation (Ciucanu & Kerek, 1984), where GC–MS  of resulting
O-methylalditol acetates showed the presence of branched
structures, containing mainly, nonreducing end-units of Fucp
(2,3,4-Me3Fuc), besides the 6-O-(2,3,4-Me3Gal) and 2,6-di-O-
substituted units (3,4-Me2Gal) of galactopyranose. Nonreducing
end-units of Galp (2,3,4,6-Me4Gal) were only detected in the
A.C. Ruthes et al. / Carbohydrate Pol
Table 1
Partially O-methylated acetates formed on methylation analysis of the fucogalactans
obtained from L. rufus (Lr) and A. bisporus (Ab) fruiting bodies: linkage types.
Partially O-methylated
alditol acetatesa
Rtb % Area of
fragmentsc
Linkage typed
RFP-Ab RFP-Lr
2,3,4-Me3-Fuc 20.03 2.8 26.9 Fucp-(1→
2,3,4,6-Me4-Gal 21.19 14.5 – Galp-(1→
2,3,4-Me3-Gal 23.67 64.8 46.0 6→)-Galp-(1→
3,4-Me2-Gal 25.76 17.9 27.1 2,6→)-Galp-(1→
a GC–MS analysis on a CP-Sil-43CB capillary column.
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ub Retention time (min).
c Based on derived O-methyalditol acetates.
d Trace.
FP-Ab isolated from A. bisporus (Table 1). The ratio of units of
ucp:2,6-di-O-Galp:6-O-Galp was ∼1:0.9:1.5 and 0.1:1:5 for RFP-Lr
rom L. rufus and RFP-Ab from A. bisporus, respectively, show-
ng the major structural difference existent when comparing the
wo isolated fucogalactanas. These values were conﬁrmed by the
ntegration of H-1 signals (5.10:5.08:5.01) present in the 1H NMR
pectrum (data not shown).
Further NMR  spectroscopy [1H, 13C and DEPT (Fig. 3), HMQC
Fig. 4), COSY and coupled HMQC (data not shown)] was also helpful
n elucidating the fucogalactan structures (Table 2).
RFP-Lr 13C NMR  (Fig. 3A) and HMQC spectra (Fig. 4A), obtained
sing D2O as solvent, had signals (C-1/H-1) at ı 103.9/5.10,
01.2/5.08, 100.9/5.08 and 100.7/4.98 corresponding to Fucp units,
,6-di-O- and 6-O-subst. Galp units, respectively. While those
rom RFP-Ab (Figs. 3B and 4B,  respectively), had C-1/H-1 sig-
als at ı 103.9/5.10, 100.7/5.05 and 100.6/5.01 corresponding
o Fucp units, 2,6-di-O- and 6-O-subst. Galp units, respectively.
nomeric signals corresponding to non-reducing end groups of -
alp  (ı 105.5/4.64) and units of 3-Me--Galp (ı 100.6/5.01) were
resent (Figs. 3B and 4B), in agreement with the methylation data
ig. 2. Elution proﬁles of fractions RFP-Ab (B) and RFP-Lr (C) determined by HPSEC
sing light scattering (- - -) and refractive index detectors (—).ymers 87 (2012) 1620– 1627 1623
indicating the presence of nonreducing end-units of -Galp
(Table 2). The glycosidic conﬁgurations of RFP-Lr and RFP-Ab fuco-
galactans units were conﬁrmed by the values of the coupling
constants JC-1/H-1 found in 1H/13C-coupled HMQC spectra. The
nonreducing end- of Fucp and the main-chain units (galactose or
3-O-Me-galactose or both) had the -conﬁguration due to respec-
tive JC-1/H-1 162.6 Hz and 172.6 Hz, respectively, while those of
nonreducing end-units of Galp from RFP-Ab had -conﬁguration,
consistent with JC-1/H-1 161.3 Hz (Perlin & Casu, 1969).
The above methylation analysis indicated the presence of 6-
O- and 2-O-subst. Galp units (Table 2), which was conﬁrmed by
NMR  spectroscopy. O-subst. C-2 signals were at ı 82.8 and 81.6
for RFP-Lr and RFP-Ab, respectively (Figs. 3 and 4), and substituted
–CH2 groups of the 6-O-(Galp e 3-O-Me-Galp) and 2,6-di-O-subst.
(Galp) units of the main chain were at ı 69.4/69.7 and 70.0, respec-
tively, giving rise to inverted signals in the DEPT spectra (Fig. 3A′
and B′). The presence and position of O-methyl groups of the het-
eropolysaccharide from A. bisporus were conﬁrmed by ı 58.9/3.43
and ı 81.6/3.58 (C/H) signals corresponding to –OCH3 and O-subst.
C-3 substituted/H-3, respectively (Figs. 3B and 4B and Table 2).
The signals of C-2/H-2 to C-6/H-6 at ı 72.0/3.90, 71.2/3.85,
74.5/73.0/3.95, 69.9/4.11 and ı 18.2/1.27 corresponded to Fucp
units, while those at ı 70.1/3.88, 81.6/3.58, 68.2/4.30, 71.7/4.21 and
ı 69.4/69.7/3.72/3.93 were from 3-O-Me-Galp units from RFP-Ab
fucogalactan (Figs. 3 and 4 and Table 2). Due to the presence of -
Galp (14.5%) of the polymer isolated from A. bisporus, the signals of
C-2 (ı 73.6), C-3 (ı 77.6), C-4 (ı 71.1), C-5 (ı 78.4) and C-6 (ı 63.6)
were enhanced in its DEPT spectrum (Fig. 2B′).
Analysis of the fucogalactan RFP-Lr from L. rufus showed it to
consist of a (1 → 6)-linked -d-galactopyranosyl main-chain, par-
tially substituted at O-2 by nonreducing end-units of -l-Fucp. That
of the RFP-Ab from A. bisporus was  related, although the main chain
was  partially O-methylated and had some -d-Galp nonreducing
end-units as substituents.
Fucogalactans similar to those now described have been iso-
lated from cultivated mycelium of Coprinus comatus (Fan et al.,
2006), fruiting bodies of Hericium erinaceus (Zhang et al., 2006),
A. brasiliensis and A. bisporus var. hortensis (Komura et al., 2010).
However, RFP-Lr had greater fucose content among the fucogalac-
tans already characterized, while RFP-Ab had more nonreducing
end-units of -Galp than the fucogalactan from the related species
A. bisporus var. hortensis (Komura et al., 2010).
3.2. Biological experiments
It is generally accepted that polysaccharides isolated from
mushrooms and plants enhance various immune responses
in vivo and in vitro. There are also many reports of mushroom
polysaccharide-induced nonspeciﬁc resistance against diverse
microbial pathogens.
In order to determine effects on murine sepsis of the fuco-
galactans RFP-Ab and RFP-Lr, isolated from A. bisporus and L. rufus,
respectively, they were tested at doses of 30 mg  kg−1. Thus their
effects on the survival rate of infected mice, neutrophil inﬂux, and
cytokine levels were determined.
The results of the survival experiments are shown in Fig. 5A.
Mice treated with saline started to die between 12 h and 24 h after
CLP, with a death rate reaching 37.5% and 87.5% at 24 h and 72 h
post-CLP, respectively. The overall mortality at the end of the obser-
vation period was 100%. The lethality was  markedly delayed in mice
treated with both fucogalactans, RFP-Ab and RFP-Lr. At 24 h and
72 h after CLP, the mortality rate in RFP-Lr group was zero and 25%,
respectively. At the end of the study, the overall survival in this
group was  62.5%. As for RFP-Ab, at 24 h and 72 h after CLP, their
mortality rate was  zero and 37.5%, respectively, with an overall
survival of 50.0% (Fig. 5A). Dexamethasone-treated mice showed a
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Table  2
1H and 13C NMR  chemical shifts [expressed as ı (ppm)] of the fucogalactans from A. bisporus (RFP-Ab) and L. rufus (RFP-Lr).a
Units 1 2 3 4 5 6 -O-CH3
a b
-l-Fucp-(1→
13C 103.9 72.0 71.2 74.5/73.0 69.9 18.2 – –
1H 5.10 3.85 3.89 3.85 4.20 1.27 – –
-d-Galp-(1→
13C 105.5 73.6 77.6 71.1 78.4 63.6 – –
1H 4.64 3.85 3.84 4.08 3.58 3.80 – –
2,6→)--d-Galp-(1→
13C 101.2/100.7 82.8/79.4 71.1 72.2 71.7 69.7 69.7 –
1H 5.08 3.61/3.84 4.08 4.09 4.21 3.70 4.01 –
6→)--d-Galp-(1→
13C 100.7 71.1 72.4 72.4 71.7 69.3 69.3 –
1H 5.01 3.84 3.89 4.03 4.21 3.72 3.93 –
13C 100.6 70.1 81.6 68.2 71.7 69.4 69.4 58.9
s
o
i
a
t
r
l
i
r
r6→)-3-O-Me--d-Galp-(1→ 1H 5.01 3.88 
a Assignments are based on 13C, 1H, DEPT, COSY and HMQC examination.
igniﬁcant improvement in survival, with an overall survival rate
f 16.7% at the end of the observation period. However, this anti-
nﬂammatory medicine signiﬁcantly delayed the onset of death
fter CLP (∼36 h versus saline group). No death was  observed in
he sham-operated mice.
In terms of neutrophil inﬂux, it was inhibited by polysaccha-
ide compounds. CLP surgery markedly increased ileum tissue MPO
evels compared with sham group (42.3%) (Fig. 5B). This increase
n tissue MPO  was signiﬁcantly prevented by both polysaccha-
ides RFP-Lr and RFP-Ab, with an inhibition of 43.0% and 51.9%,
espectively, versus saline group (Fig. 5B). Dexamethasone, the
Fig. 3. 13C NMR  spectra of fucogalactan fractions RFP-Lr (A) and RFP-Ab3.58 4.3 4.21 3.89 3.93 3.43
anti-inﬂammatory control, strongly inhibited the MPO  activity in
ileum (61.2%).
TNF- and IL-1 cytokines levels were lower in sham surgery
control mice. In contrast, 18 h after CLP surgery, both showed
an increase of 49% and 48%, respectively, in comparison to the
sham group (Fig. 6A and B). The treatment with both fucogalactans
showed signiﬁcant reduction in cytokine production in relation to
saline group. RFP-Lr reduced the levels of TNF- in 33.6% and 38.8%
of IL-1, while RFP-Ab reduced 36.5% and 32.3%, respectively. The
increased levels of TNF- and IL-1 were signiﬁcantly prevented
by dexamethasone (0.5 mg  kg−1), which promoted an inhibition of
 (B) with inserts of DEPT –CH2 inversion (A′ and B′ , respectively).
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Fig. 5. Effects of the polysaccharides RFP-Lr and RFP-Ab on survival rate and
on  myeloperoxidase activity in sepsis. (A) Mice were randomly divided into ﬁve
groups. All groups except the sham group received cecal ligation and puncture
(CLP) surgery. Saline, RFP-Lr (30 mg kg−1 s.c.), RFP-Ab (30 mg kg−1 s.c.) and dex-
amethasone (0.5 mg kg−1 s.c.) were administered immediately after surgery. The
treatment continued over the next days, each 24 h. The survival rate of mice was
recorded every 12 h over 7 days after CLP. (B) Mice subjected to sepsis by CLP were
treated with saline, RFP-Lr, RFP-Ab or dexamethasone immediately after surgery.
The  myeloperoxidase activity (MPO, indicator of neutrophil accumulation) was mea-
sured spectrophotometrically in ileum samples harvested 18 h after the induction
of  CLP. Results were expressed as change in optical density per milligram of protein.
Values represent means ± SEM. ***p < 0.001 and **p < 0.01, indicated value versusig. 4. 1H (obs.)/13C HMQC spectra of RFP-Lr (A) and RFP-Ab (B) of fucogalactans
ractions (chemical shifts are expressed in ı ppm).
pproximately 42%, in both cases, in comparison with saline group
Fig. 6, panels A and B).
It is believed that sepsis may  lead to aberrant host inﬂamma-
ory responses, causing cell injury and organ dysfunction. During
epsis, the intestine is considered not only to be a source of bac-
eremia but also an important target of bacterial products with
ajor functional consequences for intestinal motility and the gen-
ration of inﬂammatory mediators and recruitment of immune
ells. Neutrophil inﬁltration is an important pathophysiologic alter-
tion associated with sepsis. These cells directly damage tissue by
eleasing pro-inﬂammatory mediators, as cytokines, superoxide-
erived free radicals and lysosomal enzymes, such as MPO, which
mplify the systemic inﬂammatory response and cause multiple
rgan failure (Landry & Oliver, 2001; Mainous, Ertel, Chaudry, &
eitch, 1995).
In this study, a polymicrobial sepsis was induced by cecal lig-
tion and puncture (CLP) in mice to investigate the effects of
ucogalactans RFP-Lr and RFL-Ab. This model mimics the sepsis
n human, caused by pathogens derived from the intestinal tract,
nd is considered to closely simulate clinical situation (Otero-
nton et al., 2001). Lethality was markedly delayed in mice
eceiving both polysaccharides (see Fig. 5A). This result could be
ttributable to an anti-inﬂammatory activity, which is consistent
ith previous literature ﬁndings (Ahn et al., 2006; Kim et al.,
003; Komura et al., 2010). There are many reports of mushroom
olysaccharides inducing nonspeciﬁc resistance against diverseCLP plus saline group; ##p < 0.01, CLP plus saline versus sham. ANOVA followed by
Bonferroni’s test.
microbial pathogens in animals (Cisneros, Gibson, & Tzianabos,
1996; Kernodle, Gates, & Kaiser, 1998; Tzianabos & Cisneros, 1996),
as well as in human (Babineau, Hackford, et al., 1994; Babineau,
Marcello, et al., 1994) models. Although the mechanism that mush-
room polysaccharides induced effects is not well understood, a
key host immune response modulation caused by these mush-
room polymers appears to be central (Wasser, 2010). In addition, a
study carried out on experimental sepsis showed that a pretreat-
ment with an acidic polysaccharide isolated from the medicinal
mushroom Phellinus linteus could be able to inhibit bacterial septic
shock by suppressing TNF- production in areas of inﬂammation,
suggesting that the mushroom polysaccharide may contribute to
prolong the survival of septic shock mice (Kim et al., 2003). A
similar result was  observed at the present work, where both fuco-
galactans tested were able to decrease signiﬁcantly TNF- and also
IL-1 serum levels. Several previous studies have demonstrated
that some cytokines, especially TNF-, IL-1 and IL-6 are strongly
associated with sepsis syndrome, therefore inhibiting the pro-
inﬂammatory cytokine overproduction during early sepsis may
reduce sepsis outcome (Cohen, 2002; Ebong et al., 1999; Takala,
Nupponen, Kylanpaa-Back, & Repo, 2002). Consequently, the reduc-
tion in mice lethality caused by both fucogalactans may  be also
related to the decreasing in TNF- and IL-1 serum levels.
1626 A.C. Ruthes et al. / Carbohydrate Po
Fig. 6. Effect of fucogalactans RFP-Lr and RFP-Ab upon TNF- (A) and IL-1 (B)
production in infected mice serum. The mice, except the sham group, received
sterile saline, RFP-Lr (30 mg  kg−1 s.c.), RFP-Ab (30 mg  kg−1 s.c.) or dexametha-
sone (0.5 mg  kg−1 s.c.), which were administered during the CLP-surgery, and
the cytokines levels were evaluated 18 h after onset. Each group represents the
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iean ± SEM of four to ﬁve animals. *p < 0.05, indicated value versus CLP plus saline
roup; ##p < 0.01, CLP plus saline versus sham. ANOVA followed by Bonferroni’s test.
 false-operated group (sham) was also provided for this test.
Since MPO  is a lysosomal enzyme of polymorphonuclear leuko-
ytes that acts as a catalyst in the production of hypochlorous acid
powerful oxidant), the effects of RFP-Lr and RFP-Ab on MPO activ-
ty were also investigated. RFP-Lr and RFP-Ab could prevent the
levation of MPO  activity, indirectly indicating reductions in neu-
rophil recruitment to ileum, and also in oxidative tissue damage
Fig. 5B). This is of particular relevance because oxidative stress is
 likely mechanism for gut mucosal barrier dysfunction in sepsis,
 condition that can amplify and perpetuate the initial systemic
nﬂammatory response (Pastores, Katz, & Kvetan, 1996).
Therefore, one can suggest that A. bisporus and L. rufus fuco-
alactans have an anti-inﬂammatory action, such as those from A.
rasiliensis and A. bisporus var. hortensis (Komura et al., 2010). So
his biological effect may  be related to their structures, since it was
bserved inﬂuence of structure on biological response when simi-
ar polymers, having small differences in the main chain, such as the
resence of O-methyl groups, or more signiﬁcant ones in the side
hains, were evaluated. Based on the fucogalactans, one can sug-
est that factors like Mw and chemical structure could be signiﬁcant.
FP-Ab had a greater Mw than RFP-Lr, while both fucogalactans con-
ained a (1 → 6)-linked -d-galactopyranosyl main-chain, partially
ubstituted at O-2, RFP-Ab, besides lower amounts of -l-Fucp,
ad -d-Galp as nonreducing end-units, the latter being absent
n RFP-Lr. Consequently, determination of the polysaccharides ﬁne
tructure is signiﬁcant in understanding the relation between their
tructure and biological activity.
In summary, fucogalactans from edible A. bisporus (RFP-Ab) and
ild L. rufus (RFP-Lr) mushrooms were puriﬁed and their structures
etermined. They could prevent the lethality caused by polymicro-
ial sepsis in mice. This beneﬁcial effect seems to be, at least in part,
ue to a reduction in neutrophil migration (MPO essay), decreas-
ng of circulating pro-inﬂammatory cytokines and consequentlymers 87 (2012) 1620– 1627
protection against organ damage, although further investigation
is required to clarify the detailed mechanism.
4. Conclusions
The fucogalactans from A. bisporus and L. rufus have an anti-
inﬂammatory action, such as those from A. brasiliensis and A.
bisporus var. hortensis (Komura et al., 2010), related to their struc-
tures. The inﬂuence of structure on the biological response was
found with similar polymers, having small differences in the main
chain, such as the presence of O-methyl groups, or more signiﬁ-
cant ones in the side chains. Consequently, determination of the
ﬁne structure of the polysaccharides is signiﬁcant in understand-
ing the relation between their structure and biological activity. To
determine their mechanism of action, other biological assays are
necessary.
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